The Cyclin-dependent Kinase Inhibitor CYC202 (<b><i>R</i></b>-Roscovitine) Inhibits Retinoblastoma Protein Phosphorylation, Causes Loss of Cyclin D1, and Activates the Mitogen-activated Protein Kinase PathwaySteven R. Whittaker, Paul Workman|Cancer Research|2004Cited by 194
A Novel, Selective, and Efficacious Nanomolar Pyridopyrazinone Inhibitor of V600EBRAFSteven R. Whittaker, Caroline J. Springer|Cancer Research|2010Cited by 25